Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11745-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11745-1-AP, RRID:AB_2070266
- Product name
- CACYBP antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated CACYBP antibody (Cat. #11745-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: FC, IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Pan-analysis reveals CACYBP to be a novel prognostic and predictive marker for multiple cancers.
CacyBP promotes the development of lung adenocarcinoma by regulating OTUD5.
Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma.
A peptide rich in glycine-serine-alanine repeats ameliorates Alzheimer-type neurodegeneration.
MAB21L4 Deficiency Drives Squamous Cell Carcinoma via Activation of RET.
CACYBP Enhances Cytoplasmic Retention of P27(Kip1) to Promote Hepatocellular Carcinoma Progression in the Absence of RNF41 Mediated Degradation.
Mo B, Luo B, Wu Y
American journal of translational research 2024;16(1):12-26
American journal of translational research 2024;16(1):12-26
CacyBP promotes the development of lung adenocarcinoma by regulating OTUD5.
Bai M, Lu K, Che Y, Fu L
Carcinogenesis 2024 Aug 12;45(8):595-606
Carcinogenesis 2024 Aug 12;45(8):595-606
Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma.
Wang J, Zhang X, Ma X, Chen D, Cai M, Xiao L, Li J, Huang Z, Huang Y, Lian Y
Journal of experimental & clinical cancer research : CR 2023 Nov 16;42(1):303
Journal of experimental & clinical cancer research : CR 2023 Nov 16;42(1):303
A peptide rich in glycine-serine-alanine repeats ameliorates Alzheimer-type neurodegeneration.
Yao SY, Wang JF, Xu Z, Meng Y, Xue Y, Yang F, Yao WB, Gao XD, Chen S
British journal of pharmacology 2023 Jul;180(14):1878-1896
British journal of pharmacology 2023 Jul;180(14):1878-1896
MAB21L4 Deficiency Drives Squamous Cell Carcinoma via Activation of RET.
Srivastava A, Tommasi C, Sessions D, Mah A, Bencomo T, Garcia JM, Jiang T, Lee M, Shen JY, Seow LW, Nguyen A, Rajapakshe K, Coarfa C, Tsai KY, Lopez-Pajares V, Lee CS
Cancer research 2022 Sep 2;82(17):3143-3157
Cancer research 2022 Sep 2;82(17):3143-3157
CACYBP Enhances Cytoplasmic Retention of P27(Kip1) to Promote Hepatocellular Carcinoma Progression in the Absence of RNF41 Mediated Degradation.
Lian YF, Huang YL, Zhang YJ, Chen DM, Wang JL, Wei H, Bi YH, Jiang ZW, Li P, Chen MS, Huang YH
Theranostics 2019;9(26):8392-8408
Theranostics 2019;9(26):8392-8408
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human brain tissue were subjected to SDS PAGE followed by western blot with 11745-1-AP(CACYBP antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of HepG2 cells, using CACYBP antibody 11745-1-AP at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).Blue pseudocolor = DAPI (fluorescent DNA dye).
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human gliomas using 11745-1-AP(CACYBP antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
